Article History
Received: 20 January 2021
Revised: 3 May 2021
Accepted: 13 May 2021
First Online: 28 May 2021
Conflict of interest
: Dr. Carpenter reports research support from Neuronetics, Affect Neuro, Janssen, Nexstim, and Neosync. She has received income for consulting from Neuronetics, Affect Neuro, Nexstim, Janssen, Neurolief, Sage Therapeutics, Otsuka, and Sunovion. Dr. Leuchter discloses that within the past 36 months he has received research support from the National Institutes of Health, Department of Defense, CHDI Foundation, and NeuroSigma, Inc. He has served as a consultant to NeoSync, Inc., Ionis Pharmaceuticals, Inc., and ElMindA. He is Chief Scientific Officer of Brain Biomarker Analytics LLC (BBA). Dr. Leuchter has equity interest in BBA. Jeff Voigt has in the past received consulting fees for reimbursement work performed for Magstim. However, he received no remuneration for this analysis nor; was Magstim aware of its existence.